Retraction note: Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice (Molecular and Cellular Biochemistry, (2015), 407, 1-2, (263-279), 10.1007/s11010-015-2474-3);Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice

Molecular and Cellular Biochemistry

Volumn 407, Issue 1-2, 2015, Pages 263-279

  Geetha, Rajagopalan ^a   Radika, Mutulur Krishnamoorthy ^a   Priyadarshini, Emayavaramban ^a   Bhavani, Krishnamurthy ^b   Anuradha, Carani Venkatraman ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Cardiac dysfunction; Fibrosis; High fat high fructose diet; Metabolic syndrome; Oxidative stress; Troxerutin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GELATINASE A; GELATINASE B; MYOSIN LIGHT CHAIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR; TROPONIN I; TROXERUTIN; CALCIUM; FRUCTOSE; MONOXERUTIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; ECG ABNORMALITY; FOOD INTAKE; GLUCOSE TOLERANCE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART SIZE; HEART WEIGHT; HIGH FRUCTOSE DIET; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC SYNDROME X; MOUSE; MUS MUSCULUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; QRS INTERVAL; QT INTERVAL; RR INTERVAL; ST SEGMENT; TREATMENT DURATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE CELL; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; METABOLISM; PATHOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; CALCIUM; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FIBROSIS; FRUCTOSE; GENE EXPRESSION REGULATION; HYDROXYETHYLRUTOSIDE; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MICE; MYOCYTES, CARDIAC;

EID: 84939262484     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-024-05046-5     Document Type: Erratum

References (59)

1. Sawant A, Mankeshwar R, Shah S, Raghavan R, Dhongde G, Raje H et al (2011) Prevalence of metabolic syndrome in urban India. Cholesterol 2011. doi:10.1155/2011/920983
2. Miller A, Adeli K (2008) Dietary fructose and metabolic syndrome. Curr opin Gastreoenterol 24:204–209
3. Barbosa-da-Silva S, Sarmento IB, Lonzetti Bargut TC, Souza-Mello V, Aguila MB, Mandarim-de-Lacerda CA (2014) Animal models of nutritional induction of type 2 diabetes mellitus. Int J Morphol 32:279–293
4. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V et al (2011) High-carbohydrate, high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57:611–624
5. Tian YQ, Li SS, Su XD, Zhang GZ, Zhao JJ, Li GW et al (2012) Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats. J Cardiovasc Pharmacol Ther 17:223–228
6. Gradman AH, Alfayoumi F (2006) From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48:326–341
7. Hori M, Nishida K (2009) Oxidative stress and left ventricular remodeling after myocardial infarction. Cardiovasc Res 1:457–464
8. Sun Y (2009) Myocardial repair/remodeling following infarction: roles of local factors. Cardiovasc Res 81:482–490
9. Fan D, Takawale A, Lee J, Kassiri Z (2012) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 5:15
10. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ et al (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112:544–552
11. Stull LB, Matteo RG, Sweet WE, Damron DS, Moravec CS (2001) Changes in calcium cycling precede cardiac dysfunction during autoimmune myocarditis in mice. J Mol Cell Cardiol 33:449–460
12. 2+ permeable cation channels by myocarditis-associated antibody in guinea pig ventricular myocytes. J Clin Invest 91:1231–1234
13. Ärnlöv J, Ingelsson E, Sundström J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 21:230–236
14. Fan SH, Zhang ZF, Zheng YL, Lu J, Wu DM, Shan Q et al (2009) Troxerutin protects the mouse kidney from D-galactose-caused injury through anti-inflammation and anti-oxidation. Int Immunopharmacol 9:91–96
15. Maurya DK, Balakrishnan S, Salvi VP, Nair CK (2005) Protection of cellular DNA from c-radiation-induced damages and enhancement in DNA repair by troxerutin. Mol Cell Biochem 280:57–68
16. Vin F, Chabanel A, Taccoen A, Ducros J, Gruffiaz J, Hutinel B et al (1994) Double blind trial of the efficacy of troxerutin in chronic venous insufficiency. Phlebologie 9:71–78
17. Siegers CP, Ali SS, Tegtmeier M (2008) Aescin and troxerutin as a successful combination for the treatment of inner ear perfusion disturbances. Phytomedicine 15:160–163
18. Geetha R, Yogalakshmi B, Sreeja S, Bhavani K, Anuradha CV (2014) Troxerutin suppresses lipid abnormalities in the heart of high-fat–high-fructose diet-fed mice. Mol Cell Biochem 387:123–134
19. Bhuvaneswari S, Arunkumar E, Viswanathan P, Anuradha CV (2010) Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet. Process Biochem 45:1406–1414
20. 120): comparison with other measures. Diabetes Res Clin Pract 47(3):177–184
21. Witko-Sarsat V, Friedlander M, Capeille`re-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313
22. Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of ‘‘antioxidant power’’: the FRAP assay. Anal Biochem 239:70–76
23. Ramesh T, Begum VH (2008) Protective effect of Sesbania grandiflora against cigarette smoke-induced oxidative damage in rats. J Med Food 11:369–375
24. Barzegar A, Moosavi-Movahedi AA (2011) Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 6:e26012
25. Woessner JF Jr (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447
26. Yin FCP, Spurgeon HA, Rakusan K, Weisfeldt M, Lakatta EG (1982) Use of tibia length to quantify cardiac hypertophy: application in the aging rat. Am J Physiol 246:H941–H947
27. Makowski GS, Ramsby ML (1996) Calibrating gelatin zymograms with human gelatinase standards. Anal Biochem 236:353–356
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin’s-Phenol reagent. J Biol Chem 193:265–275
29. Somaratne JB, Whalley GA, Poppe KK, ter Bals MM, Wadams G, Pearl A, Bagg W, Doughty RN (2011) Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol 10:29
30. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP et al (2005) Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179:43–49
31. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279:45935–45941
32. Feillet-Coudray C, Sutra T, Fouret G, Ramos J, Wrutniak-Cabello C, Cabello G et al (2009) Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 46:624–632
33. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M et al (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939–1945
34. Karthik D, Viswanathan P, Anuradha CV (2011) Administration of rosmarinic acid reduces cardiopathology and blood Pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats. J Cardiovasc Pharmacol 58:514–521
35. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF et al (2007) Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38:3016–3022
36. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF et al (2008) Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension 51:296–301
37. Li J-W, Guo Z-X (2011) Effects of telmisartan on the expression of NADPH oxidase subunits in the myocardium of type 2 diabetic rats. Med J Chin Peoples Lib Army 36:1037–1040
38. Guo Z, Zhang R, Li J, Xu G (2012) Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats. Cardiovasc Diabetol 11:94
39. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500–508
40. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ et al (2006) Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26:1156–1162
41. Blasig I, Loewe H, Ebert B (1987) Radical trapping and lipid peroxidation during myocardial reperfusion injury–radical scavenging by troxerutin in comparison to mannitol. Biomed Biochim Acta 46:S539–S544
42. Blasig IE, Loewe H, Elbert B (1988) Effect of troxerutin and methionine on spin trapping of free oxy-radicals. Biomed Biochim Acta 47:S252–S255
43. Wenisch C, Biffignandi PM (2001) Effect of bioflavonoids (trihydroxyethylrutin and disodium flavodate) in vitro on neutrophil reactive oxygen production and phagocytic ability assessed by flow cytometry. Curr Med Res Opin 2:123–127
44. Kessler M, Ubeaud G, Walter T, Sturm F, Jung L (2002) Free radical scavenging and skin penetration on troxerutin and vitamin derivatives. Dermatolog Treat 13:133–141
45. Lee KS, Cha HJ, Lee GT, Lee KK, Hong JT, Ahn KJ et al (2014) Troxerutin induces protective effects against ultraviolet B radiation through the alteration of microRNA expression in human HaCaT keratinocyte cells. Int J Mol Med 33:934–942
46. Villar AV, Cobo M, Llano M, Montalvo C, Vílchez F, Durán RM et al (2009) Plasma levels of transforming growth factor-β1 reflect left ventricular remodeling in aortic stenosis. PLoS One 12:e8476
47. Meyer A, Wang W, Qu J, Croft L, Degen JL, Coller BS, Ahamed J (2012) Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood 119:1064–1074
48. Wu L, Derynck R (2009) Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. Dev Cell 17:35–48
49. Celik A, Ersoy OF, Ozkan N, Kayaoqlu HA, Ozuqurlu F, Cakir EA et al (2010) Comparison of the effects of troxerutin and heparinoid on flap necrosis. J Plast Reconstr Aesthet Surg 5:875–883
50. Chung HK, Choi SM, Ahn BO, Kwak HH, Kim JH, Kim WB (2005) Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 55:573–580
51. Lu J, Wu DM, Hu B, Zheng YL, Zhang Z, Wang YJ (2010) NGF-Dependent activation of TrkA pathway: a mechanism for the neuroprotective effect of troxerutin in D-galactose-treated mice. Brain Pathol 5:952–965
52. Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285–1342
53. Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E et al (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the biomarker evaluation for antioxidant therapies in stroke (BEAT-Stroke) study. Stroke 39:100–104
54. Viappiani S, Nicolescu AC, Holt A, Sawicki G, Crawford BD, León H et al (2009) Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol 77:826–834
55. Kandasamy AD, Chow AK, Ali MA, Schulz R (2010) Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res 85:413–423
56. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity role of oxidative stress. Circ Res 88:1291–1298
57. Ruetten H, Badorff C, Ihling C, Zeiher AM, Dimmeler S (2001) Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol 38:2063–2070
58. Ermak G, Davies KJ (2002) Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38:713–721
59. Tabet F, Savoia C, Schiffrin EL, Touyz RM (2004) Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 44:200–208